NO20071357L - "Fremgangsmate ved utvinning av faktor VIII:C" - Google Patents

"Fremgangsmate ved utvinning av faktor VIII:C"

Info

Publication number
NO20071357L
NO20071357L NO20071357A NO20071357A NO20071357L NO 20071357 L NO20071357 L NO 20071357L NO 20071357 A NO20071357 A NO 20071357A NO 20071357 A NO20071357 A NO 20071357A NO 20071357 L NO20071357 L NO 20071357L
Authority
NO
Norway
Prior art keywords
recovery
procedure
factor viii
viii
factor
Prior art date
Application number
NO20071357A
Other languages
English (en)
Other versions
NO326257B1 (no
Inventor
Friedrich Dorner
Johann Eibl
Artur Mitterer
Bernard Fischer
Oyving L Schonberger
Kathrin Thomas Urban
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3487946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071357(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20071357L publication Critical patent/NO20071357L/no
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO326257B1 publication Critical patent/NO326257B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071357A 1997-02-27 2007-03-13 "Fremgangsmate ved utvinning av faktor VIII:C" NO326257B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033897A AT406373B (de) 1997-02-27 1997-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
PCT/AT1998/000043 WO1998038220A1 (de) 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Publications (2)

Publication Number Publication Date
NO20071357L true NO20071357L (no) 1999-08-26
NO326257B1 NO326257B1 (no) 2008-10-27

Family

ID=3487946

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19994137A NO324902B1 (no) 1997-02-27 1999-08-26 Fremgangsmate ved utvinning av faktor VIII/vWF-kompleks ved hjelp av kationebytterkromatografi, faktor VIII/vWF-kompleks saledes fremstilt, samt preparat inneholdende samme og anvendelse derav
NO20071357A NO326257B1 (no) 1997-02-27 2007-03-13 "Fremgangsmate ved utvinning av faktor VIII:C"

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19994137A NO324902B1 (no) 1997-02-27 1999-08-26 Fremgangsmate ved utvinning av faktor VIII/vWF-kompleks ved hjelp av kationebytterkromatografi, faktor VIII/vWF-kompleks saledes fremstilt, samt preparat inneholdende samme og anvendelse derav

Country Status (11)

Country Link
US (3) US6831159B1 (no)
EP (1) EP0971958B2 (no)
JP (1) JP4250771B2 (no)
AR (2) AR010121A1 (no)
AT (2) AT406373B (no)
AU (1) AU744919B2 (no)
CA (1) CA2282841C (no)
DE (1) DE59814211D1 (no)
ES (1) ES2306471T5 (no)
NO (2) NO324902B1 (no)
WO (1) WO1998038220A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
EP2349314B1 (en) 2008-10-21 2013-02-27 Baxter International Inc. Lyophilized recombinant vwf formulations
MX2012002129A (es) * 2009-08-20 2012-06-08 Baxter Int Purificacion del factor de von willebrand (vwf) para remocion incrementada de virus envueltos sin lipido.
RU2579977C2 (ru) 2009-11-13 2016-04-10 Грифольс Терапьютикс Инк. СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ
WO2012015908A2 (en) 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient
CN103732244A (zh) * 2011-06-10 2014-04-16 巴克斯特国际公司 通过施用重组vwf治疗凝血疾病
AU2012290004B2 (en) 2011-08-02 2014-11-27 Takeda Pharmaceutical Company Limited Systems and methods to increase protein yield from recombinant manufacturing processes
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
WO2014083510A1 (en) * 2012-11-30 2014-06-05 Centre For Bioseparation Technology - Vit Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
ES2693380T3 (es) 2013-11-08 2018-12-11 Csl Limited Nuevo método para concentrar el factor de von Willebrand o complejos de este
WO2015196250A1 (en) 2014-06-27 2015-12-30 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
KR102386838B1 (ko) 2013-12-18 2022-04-15 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 장쇄 다중불포화 지방산을 포함하는 지질
EP3188816B1 (en) 2014-09-02 2021-06-09 EMD Millipore Corporation Chromatography media comprising discrete porous bundles of nanofibrils
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
FI3648788T5 (fi) 2017-07-07 2024-09-09 Takeda Pharmaceuticals Co Maha-suolikanavan verenvuodon hoito vaikeaa von willebrandin tautia sairastavilla potilailla antamalla rekombinanttia vwf:ää
JP7326246B2 (ja) 2017-07-07 2023-08-15 武田薬品工業株式会社 待機手術を受ける、重度のフォンヴィレブランド病を患う患者の、組換えｖｗｆの投与による治療法
EA202192140A1 (ru) 2019-02-01 2021-12-15 Такеда Фармасьютикал Компани Лимитед СПОСОБЫ ПРОФИЛАКТИЧЕСКОГО ЛЕЧЕНИЯ РЕКОМБИНАНТНЫМ ФВ (рФВ)
CN114106145B (zh) * 2021-10-22 2023-09-01 山东泰邦生物制品有限公司 一种血源人凝血因子ⅷ/血管性血友病因子复合物生产工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
NZ237244A (en) 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
CA2251558C (en) 1996-04-12 2005-11-22 Immuno Aktiengesellschaft Highly purified factor viii complex
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Also Published As

Publication number Publication date
ES2306471T3 (es) 2008-11-01
NO994137L (no) 1999-08-26
US20020058625A1 (en) 2002-05-16
WO1998038220A1 (de) 1998-09-03
AR059902A2 (es) 2008-05-07
DE59814211D1 (de) 2008-05-21
AU6080698A (en) 1998-09-18
AT406373B (de) 2000-04-25
US6831159B1 (en) 2004-12-14
EP0971958A1 (de) 2000-01-19
US7648958B2 (en) 2010-01-19
EP0971958B2 (de) 2012-02-08
CA2282841C (en) 2008-12-02
EP0971958B1 (de) 2008-04-09
NO994137D0 (no) 1999-08-26
AU744919B2 (en) 2002-03-07
ATA33897A (de) 1999-09-15
ES2306471T5 (es) 2012-06-07
NO326257B1 (no) 2008-10-27
ATE391728T1 (de) 2008-04-15
AR010121A1 (es) 2000-05-17
JP4250771B2 (ja) 2009-04-08
JP2001517212A (ja) 2001-10-02
US20050239171A1 (en) 2005-10-27
CA2282841A1 (en) 1998-09-03
NO324902B1 (no) 2007-12-27
US6953837B2 (en) 2005-10-11

Similar Documents

Publication Publication Date Title
NO970939D0 (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
IT1284108B1 (it) Presidio chirurgico per il trattamento dell'enfisema polmonare
NO942090D0 (no) Fremgangsmåte ved fremstilling av siliciumkarbid
NO994084L (no) Fremgangsmaate ved utvinning av höyren vWF eller faktor VIII/vWF-kompleks
PL326604A1 (en) Derivatives of 5"-dezoxy-cytidin
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
FI973407A7 (fi) Kirurgin takki
ITBO960063A0 (it) Composti ad attivita' di fissaggio di gas
DE69610037D1 (de) Verfahren zur Herstellung von 2-(2'-Hydroxyphenol)-Benzotriazolverbindungen
IT1289989B1 (it) Processo per l'idrossilazione di idrocarburi aromatici
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
FR2767343B1 (fr) Geofilet pour la protection de sols contre l'erosion
NO994749L (no) Fremgangsmåte ved fremstillingen av tetraazamakrocykler
FR2726824B1 (fr) Composition d'alcoxysilanes protegee de la reaction de dismutation
IT1277680B1 (it) Procedimento per l'alchilazione di composti aromatici
NO930223D0 (no) Fremgangsmaate ved fremstilling av 4,6-dialkoksypyrimidiner
DE69802312D1 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
ITBO940208A0 (it) Pistola perfezionata per l'applicazione di collante
NO975384D0 (no) Fremgangsmåte for syntese av deoksypyridinolin
FR2756310B1 (fr) Montant auxiliaire d'echafaudage
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
AU4300397A (en) Process for the manufacture of (2'-fluorophenyl)-3-halopyridines
UA1796S (uk) Комплект етикеток для вина "україна"
UA1719S (uk) Комплект етикеток для горілки "банкетна"
UA1879S (uk) Комплект етикеток для горілки "староруська"

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAXALTA INCORPORATED, CH

MK1K Patent expired